AXT to distribute 'mini synchrotron'
Lyncean Technologies, the manufacturer of the Lyncean Compact Light Source (CLS), has signed scientific equipment supplier AXT as its exclusive representative in Australia and New Zealand.
Comparable in size to a stadium, a synchrotron requires massive infrastructure investments and a significant number of highly technical support staff. The CLS is 200 times smaller yet comparable in light intensity, allowing it to fit in a typical laboratory space and to be more easily accessed by researchers.
Unlike conventional laboratory sources, the CLS creates a narrow beam of nearly monochromatic X-rays which are adjustable in energy — a feature unique to synchrotron radiation. Suitable for numerous imaging, diffraction, fluorescent and scattering experiments carried out at synchrotron facilities, it is designed to be operated by a postdoc, graduate student or beamline scientist.
AXT will be responsible for growing the academic research market for Lyncean as well as providing frontline service and operational support for future installations.
“We are excited to represent Lyncean and see a tremendous potential for the Lyncean Compact Light Source as a complement to the Australian Synchrotron,” said AXT Managing Director Richard Trett. “Both university researchers and beamline scientists at the synchrotron have voiced the desire for a regionally located, laboratory-based source. It provides a complementary capability, additional beamline capacity, and could be used for optimising experiments. It also opens up whole new areas of science, in particular to experimentalists unable to travel with their experiments or who can’t gain access to the required time on beam lines.”
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a...
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...